East Africa’s healthcare industry, Katongole, holds a significant 2.79-percent stake in CiplaQCIL.
Ugandan pharma tycoon
-
-
CiplaQCIL’s total assets have surpassed $64 million.
-
Katongole owns 2.79 percent of the company, which translates to 101,933,042 ordinary shares.